ROIV vs SYRE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ROIV Captures Institutional Edge (2โ1 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Roivant Sciences Ltd. Common Shares (ROIV) driven by superior Growth & Margin, Options & Structure while SYRE counters with relative strength in Momentum & Technical. Fundamentally, ROIV trades at N/M Forward P/E with -3226.3% operating margin (+2135.6% YoY revenue) versus SYRE at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ROIV sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against SYRE sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ROIV | SYRE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $28.7B | $9.8B | Larger Scale | ROIV |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +2135.6% | +0.0% | Higher Growth | ROIV |
| Operating Margin (TTM) Profitability | -3226.3% | 0.0% | Higher Margin | SYRE |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -8.5% | -35.0% | Higher ROE | ROIV |
| 52-Week Range Position Momentum | 84% ($20โ$42) | 88% ($22โ$111) | Stronger Trend | SYRE |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 49% Vol | 1.75ฮฒ ยท 59% Vol | Lower Realized Risk | ROIV |
| Unified Institutional Score Composite Signal | 39.6 / 100 (SELL) | 44.4 / 100 (HOLD) | Higher Composite | SYRE |